1. Home
  2. Myeloproliferative neoplasm
  Subject:

Myeloproliferative neoplasm   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Janus kinase 2 Myelofibrosis Polycythemia vera Essential thrombocytosis Allele Thrombosis Thrombocytosis Splenomegaly Myeloid tissue Mutation Myeloproliferative neoplasm Hydroxycarbamide Gene Single-nucleotide polymorphism Polymerase chain reaction DNA Zygosity Syndrome Stent Infarction Disease Platelet Bone marrow CT scan Portal hypertension Lymphadenopathy Acute myeloid leukemia Haematopoiesis Hematopoietic stem cell Protein Phenotype Acid
RELATED SUBJECTS:
The publications listed also have these subjects
Janus kinase 2  9 times
Myelofibrosis  7 times
Allele  3 times
Thrombosis  2 times
Splenomegaly  2 times
Myeloid tissue  2 times
Mutation  2 times
Hematopoietic stem cell  2 times
Haematopoiesis  2 times
Gene  2 times
Fibrosis  2 times
Disease  2 times
DNA sequencing  2 times
Chronic myelogenous leukemia  2 times
Bone marrow  2 times
Aspirin  2 times
Acute myeloid leukemia  2 times
Tyrosine kinase  1 time
Thrombocytopenia  1 time
Telomerase  1 time
Syndrome  1 time
Sanger sequencing  1 time
Programmed cell death protein 1  1 time
Platelet  1 time
Philadelphia  1 time
Phenotype  1 time
P53  1 time
Lithuania  1 time
Leukocytosis  1 time
Kinase  1 time
Karyotype  1 time
Janus  1 time
Interferon  1 time
India  1 time
Immune tolerance  1 time
Immune system  1 time
Immune checkpoint  1 time
IDH1  1 time
Hematology  1 time
Finnish language  1 time
Exome  1 time
Epigenetics  1 time
EZH2  1 time
Cytokine  1 time
Collagen  1 time
Atrial fibrillation  1 time

Publications tagged with this subject: 13

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms

2. Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature

3. Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms

4. Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms

5. BCR-ABL and JAK2V617F Mutation Co-existence, Rare or Just Unexplored

6. Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory

7. Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden

8. Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender

9. Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera

10. Improved outcome of childhood acute myeloid leukemia in an Eastern European country: Lithuanian experience

11. Contemporary Use of Interferon Therapy in the Myeloproliferative Neoplasms

12. Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis

13. Pharmacotherapy of Myelofibrosis


Questions?

Drop us a message.